Turkish Journal of Oncology Turkish Society for Radiation Oncology
Article Open Access Volume 28 · Issue 4 · 2013 pp. 143–149

Clinical features and prognostic factors of hepatocellular carcinoma patients; single center experience

Recep ALANLI1
1 Ankara Numune Eğitim ve Araştırma Hastanesi, İç Hastalıkları Kliniği, Ankara
2 Manisa Devlet Hastanesi, Tıbbi Onkoloji Bölümü, Manisa
3 Ankara Numune Eğitim ve Araştırma Hastanesi, Tıbbi Onkoloji Kliniği, Ankara
4 Hacettepe Üniversitesi Onkoloji Enstitüsü, Tıbbi Onkoloji Bilim Dalı, Ankara
Published: 2013 Article ID: 870
Abstract
OBJECTIVES

We aimed to evaluate the etiologic, demographic factors, clinical
features and also prognostic factors which effect the survival
of hepatocellular cancer (HCC) patients.


METHODS

We retrospectively analyzed 213 HCC patients who were diagnosed
at medical oncology clinic.


RESULTS

Fourth (18.8%) chronic alcoholic, 142 (66.7%) hepatitis B,
and 26 (12.2%) patients were hepatitis C. Median overall survival
was 5.5 months (95% CI: 3.5-7.5). We detected statically
significant effect of ECOG performance status, Child-Pugh
score, portal venous thrombosis, levels of albumin, bilirubin,
AST and AFP, presence of cirrhosis and the choice of treatment
modality on overall survival. Assessment of response to
first-line chemotherapy, 65 (91.5%) patients had progressive
disease, two (2.8%) patients had stable disease, four (5.6%)
patients had a partial response.


CONCLUSION

Viral hepatitis is the major leading etiological factors of HCC
in our country. Despite all efforts, shorter life spans and cytotoxic
therapies are not effective in this disease.

Keywords: Hepatocellular cancer; prognostic factors; survival

Article information

7,231 Views
5,065 Downloads
View / Download PDF

Current Issue Vol 28 · Iss 4

Submit manuscript
Most read & early access
Click an article to open abstract.
No early access articles.
View all articles